Symbyax and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Symbyax (fluoxetine hydrochloride; olanzapine), especially for people who are female, 40-49 old, also take Navane, and have Psychotic disorder.

The phase IV clinical study analyzes which people have Panic attacks when taking Symbyax. It is created by eHealthMe based on reports of 1,347 people who have side effects when taking Symbyax from the FDA, and is updated regularly.

What is Symbyax?

Symbyax has active ingredients of fluoxetine hydrochloride; olanzapine. It is often used in depression. eHealthMe is studying from 1,449 Symbyax users. Check the latest studies of Symbyax.

What is Panic attacks?

Panic attacks is found to be associated with 2,130 drugs and 2,076 conditions by eHealthMe. Check the latest studies of Panic attacks.

On May, 09, 2026

1,347 people reported to have side effects when taking Symbyax.
Among them, 17 people (1.26%) have Panic attacks.

Among these 17 people:

What is the gender of people who have Panic attacks when taking Symbyax? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Panic attacks when taking Symbyax? *

What are other drugs people take besides Symbyax? *

What are other side effects people have besides Panic attacks? *

Drowsiness: 12 people, 70.59%
Headache (pain in head): 9 people, 52.94%
Gallstones (stone formation by bile component): 8 people, 47.06%
Pancreatitis (inflammation of pancreas): 8 people, 47.06%
Dizziness: 8 people, 47.06%
Ovarian Cysts (fluid filled sacs of the ovary): 8 people, 47.06%
Arrhythmias (irregular heartbeat): 8 people, 47.06%
Food Craving: 8 people, 47.06%
Gastric Ulcer (stomach ulcer): 8 people, 47.06%
Diabetes: 8 people, 47.06%

What are the existing conditions these people have? *

Psychotic Disorder: 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take Symbyax and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Symbyax:

Symbyax (1,449 reports)

Panic attacks treatments and more:

Panic attacks (65,704 reports)

How severe was Panic attacks and when was it recovered:

Panic attacks in Symbyax

Expand to all the drugs that have ingredients of fluoxetine hydrochloride; olanzapine:

Panic attacks and drugs with ingredients of fluoxetine hydrochloride; olanzapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbyax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,130 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,076 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride; olanzapine (the active ingredients of Symbyax) and Symbyax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.